advertisement

---

Clark KL 14

Showing records 1 to 14 | Display all abstracts from Clark KL

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Coleman RA; Coleman RA
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodward DF; Wang JW
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Woodrooffe AJ; Woodrooffe AJ
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Coleman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Clark KL
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Coleman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Clark KL
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodrooffe AJ
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Toris CB
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodrooffe AJ; Clark KL; Clark KL
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Fan S
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Stamer WD
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---

80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Wang JW; Woodward DF
British Journal of Pharmacology 2019; 176: 687-698

---

80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Tao G; Fan S; Toris CB
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

---